Lead Product(s) : S007-867
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : IND Enabling
Sponsor : Marc Laboratories
Deal Size : Undisclosed
Deal Type : Agreement
CSIR-CDRI Signs Agreement with Marc Labs to Develop Drug for Heart Attack and Stroke
Details : The agreement has been signed for the development of a synthetic compound S-007-867 as modulator of blood coagulation cascade, in particular as inhibitor of collagen induced platelet aggregation.
Product Name : S007-867
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
December 06, 2021
Lead Product(s) : S007-867
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : IND Enabling
Sponsor : Marc Laboratories
Deal Size : Undisclosed
Deal Type : Agreement